CAFC Upholds Win for Janssen on Patent for Antipsychotic Med Dosing Regimen
The U.S. Court of Appeals for the Federal Circuit affirmed that Teva Pharmaceuticals did not prove the claims of Janssen Pharmaceuticals' patent for antipsychotic dosing regimens invalid for obviousness.
Split En Banc CAFC Says Google Gets a New Trial on Damages, Scrapping $20 Million Award for EcoFactor
The CAFC reversed the district court's denial of Google's new trial motion in EcoFactor v. Google, emphasizing the role of factual sufficiency in expert testimony.